TRANSFAC-Logo

TRANSFAC FACTOR TABLE, Release 2017.2 - public - 2017-06-30, (C) QIAGEN


AC T09633 XX ID T09633 XX DT 08.11.2006 (created); man. DT 22.11.2007 (updated); ssr. CO Copyright (C), QIAGEN. XX FA FXR XX SY BAR; bile acid receptor; farnesoid X activated receptor; HRR-1; HRR1; NR1H4; retinoid X receptor interacting protein 14; RIP-14; RIP14. XX OS rat, Rattus norvegicus OC eukaryota; animalia; metazoa; chordata; vertebrata; tetrapoda; mammalia; eutheria; rodentia; myomorpha; muridae; murinae XX GE G002744 Nr1h4. XX CL C0002; CC (rec); 2.1.2.7.3.4. XX SZ 469 AA; 53.9 kDa (cDNA) (calc.). XX SQ MNLIGPSHLQATDEFALSENLFGVLTEHAAGPLGQNLDLESYSPYNNVQFPQVQPQISSS SQ SYYSNLGFYPQQPEDWYSPGLYELRRMPTESVYQGETEVSEMPVTKKPRMAASSAGRIKG SQ DELCVVCGDRASGYHYNALTCEGCKGFFRRSITKNAVYKCKNGGNCVMDMYMRRKCQDCR SQ LRKCREMGMLAECLLTEIQCKSKRLRKNVKQHADQTVNEDSEGRDLRQVTSTTKLCREKT SQ ELTVDQQTLLDYIMDSYSKQRMPQEITNKILKEEFSAEENFLILTEMATSHVQILVEFTK SQ RLPGFQTLDHEDQIALLKGSAVEAMFLRSAEIFNKKLPAGHADLLEERIRKSGISDEYIT SQ PMFSFYKSVGELKMTQEEYALLTAIVILSPDRQYIKDREAVEKLQEPLLDVLQKLCKIYQ SQ PENPQHFACLLGRLTELRTFNHHHAEMLMSWRVNDHKFTPLLCEIWDVQ XX SC translated from EMBL #U18374 XX FT 121 192 SM00399; c4gold. FT 121 196 PS51030; NUCLEAR_REC_DBD_2. FT 122 197 PF00105; Zinc finger, C4 type (two domains). FT 124 189 putative DNA-binding domain [1]. FT 250 469 putative ligand-binding domain [1]. FT 286 441 SM00430; holi. FT 289 465 PF00104; Ligand-binding domain of nuclear hormon. XX IN T08433 RXR-alpha; human, Homo sapiens. XX MX M07256 V$FXRRXR_Q5. MX M01268 V$FXR_Q2. MX M00631 V$FXR_Q3. MX M03790 V$FXR_Q5. MX M03795 V$LXR_Q6. MX M00964 V$PXR_Q2. XX BS R09991. BS R09990. BS R09968. XX DR TRANSPATH: MO000090868. DR EMBL: U18374; DR UniProtKB: Q62735; XX RN [1]; RE0016189. RX PUBMED: 7774010. RA Forman B. M., Goode E., Chen J., Oro A. E., Bradley D. J., Perlmann T., Noonan D. J., Burka L. T., McMorris T., Lamph W. W., et a. l. RT Identification of a nuclear receptor that is activated by farnesol metabolites RL Cell 81:687-693 (1995). RN [2]; RE0016194. RX PUBMED: 10334993. RA Parks D. J., Blanchard S. G., Bledsoe R. K., Chandra G., Consler T. G., Kliewer S. A., Stimmel J. B., Willson T. M., Zavacki A. M., Moore D. D., Lehmann J. M. RT Bile acids: natural ligands for an orphan nuclear receptor RL Science 284:1365-1368 (1999). RN [3]; RE0017935. RX PUBMED: 11867625. RA Seo Y. W., Sanyal S., Kim H. J., Won D. H., An J. Y., Amano T., Zavacki A. M., Kwon H. B., Shi Y. B., Kim W. S., Kang H., Moore D. D., Choi H. S. RT FOR, a novel orphan nuclear receptor related to farnesoid X receptor RL J. Biol. Chem. 277:17836-17844 (2002). RN [4]; RE0018127. RX PUBMED: 10360171. RA Wang H., Chen J., Hollister K., Sowers L. C., Forman B. M. RT Endogenous bile acids are ligands for the nuclear receptor FXR/BAR. RL Mol. Cell 3:543-553 (1999). RN [5]; RE0023349. RX PUBMED: 10334992. RA Makishima M., Okamoto A. Y., Repa J. J., Tu H., Learned R. M., Luk A., Hull M. V., Lustig K. D., Mangelsdorf D. J., Shan B. RT Identification of a nuclear receptor for bile acids. RL Science 284:1362-1365 (1999). RN [6]; RE0051190. RX PUBMED: 16522742. RA Honjo Y., Sasaki S., Kobayashi Y., Misawa H., Nakamura H. RT 1,25-dihydroxyvitamin D3 and its receptor inhibit the chenodeoxycholic acid-dependent transactivation by farnesoid X receptor. RL J. Endocrinol. 188:635-643 (2006). XX //